A Path Physiology of Corona Virus and its Socio-Economic Implications
Keywords:
Inadequate Immune Systems, COVID-19 epidemic, Infectious diseases, COVID-19 (Corona Virus), SymptomsAbstract
There has been growing concern about the safety and vigilance behind the corona virus SARS- CoV2 also known as COVID-19, which has had a significant impact worldwide. This has led many industries to accelerate new security technologies and to improve existing ones to deal with the highly contagious virus. Most governments around the world also adopt policies that focus on increased protection to prevent the spread of the virus and protect key personnel such as health care providers, store staff and police. This review investigates advances in bio-based antimicrobial encapsulations as an effective measure to curb the growth of COVID-19 virus in areas and reduce its spread through global contact. This will help researchers develop more sophisticated techniques in material science to focus on infectious diseases in the future.
References
N. M. Duggan, S. M. Ludy, B. C. Shannon, A. T. Reisner, and S. R. Wilcox, “Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results,” Am. J. Emerg. Med., vol. 39, pp. 256.e1-256.e3, Jan. 2021
M. A. Chilvers, M. McKean, A. Rutman, B. S. Myint, M. Silverman, and C. O’Callaghan, “The effects of coronavirus on human nasal ciliated respiratory epithelium,” Eur. Respir. J., vol. 18, no. 6, pp. 965–970, Dec. 2001
C. Garnett, S. Jackson, M. Oldham, J. Brown, A. Steptoe, and D. Fancourt, “Factors associated with drinking behaviour during COVID-19 social distancing and lockdown among adults in the UK,” Drug Alcohol Depend., vol. 219, p. 108461, Feb. 2021
S. Lee et al., “Clinical Course and Molecular Viral Shedding among Asymptomatic and Symptomatic Patients with SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea,” JAMA Intern. Med., 2020
G. Ye et al., “Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation,” J. Infect., vol. 80, no. 5, pp. e14–e17, May 2020
Q. X. Long et al., “Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections,” Nat. Med., vol. 26, no. 8, pp. 1200–1204, Aug. 2020
L. Liu et al., “High neutralizing antibody titer in intensive care unit patients with COVID-19,” Emerg. Microbes Infect., vol. 9, no. 1, pp. 1–30, Jan. 2020
L. P. Molina, S. K. Chow, A. Nickel, and J. E. Love, “Prolonged Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in an Obstetric Patient With Antibody Seroconversion,” Obstet. Gynecol., vol. 136, no. 4, pp. 838–841, Oct. 2020
F. J. Ibarrondo et al., “Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19,” N. Engl. J. Med., vol. 383, no. 11, pp. 1085–1087, Sep. 2020
L. Lan et al., “Positive RT-PCR Test Results in Patients Recovered from COVID-19,” JAMA - Journal of the American Medical Association, vol. 323, no. 15. American Medical Association, pp. 1502–1503, 21-Apr-2020
S. Singh, R. Kumar, R. Panchal, and M. K. Tiwari, “Impact of COVID-19 on logistics systems and disruptions in food supply chain,” Int. J. Prod. Res., 2020
Mansi Gupta & Vikash Yadav et al, “Proposed Framework for Dealing COVID-19 Pandemic Using Blockchain Technology”, Journal of Scientific and Industrial Research, Vol. 80, No. 3, pp. 270-275, March 2021.
